C
Andlauer Healthcare Group Inc. AND.TO
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
C
Hold 10/17/2024Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to C from C- on 10/17/2024 due to an increase in the volatility index and valuation index.
C
Hold 8/26/2024Downgrade
Andlauer Healthcare Group Inc. (AND.TO) was downgraded to C- from C on 8/26/2024 due to a decline in the solvency index, volatility index and efficiency index. Debt to equity increased from 0.11 to 0.23, the quick ratio declined from 1.82 to 1.26, and total capital declined 6.3% from $446.88M to $418.75M.
C
Hold 1/12/2024Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to C from C- on 1/12/2024 due to an increase in the volatility index and total return index.
C
Hold 12/28/2023Downgrade
Andlauer Healthcare Group Inc. (AND.TO) was downgraded to C- from C on 12/28/2023 due to a decline in the total return index and volatility index.
C
Hold 12/13/2023Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to C from C- on 12/13/2023 due to an increase in the volatility index, growth index and solvency index. Debt to equity declined from 0.16 to 0.11, and operating cash flow increased 9.35% from $19.52M to $21.35M.
C
Hold 10/20/2023Downgrade
Andlauer Healthcare Group Inc. (AND.TO) was downgraded to C- from C on 10/20/2023 due to a large decline in the total return index, growth index and volatility index. Earnings per share declined from $0.2883 to $0.2754, EBIT declined 3.97% from $17.51M to $16.82M, and total revenue declined 3.85% from $121.82M to $117.14M.
C
Hold 7/27/2023Downgrade
Andlauer Healthcare Group Inc. (AND.TO) was downgraded to C from C+ on 7/27/2023 due to a noticeable decline in the volatility index and total return index.
C
Hold 6/8/2023Downgrade
Andlauer Healthcare Group Inc. (AND.TO) was downgraded to C+ from B- on 6/8/2023 due to a major decline in the valuation index, growth index and volatility index. Operating cash flow declined 33.37% from $27.07M to $18.04M, earnings per share declined from $0.3462 to $0.2883, and EBIT declined 15.59% from $20.75M to $17.51M.
B
Buy 2/10/2023Downgrade
Andlauer Healthcare Group Inc. (AND.TO) was downgraded to B- from B on 2/10/2023 due to a noticeable decline in the total return index, growth index and volatility index. Earnings per share declined from $0.3839 to $0.3372, EBIT declined 9.62% from $23.62M to $21.35M, and total revenue declined 4.76% from $132.71M to $126.39M.
B
Buy 4/18/2022Downgrade
Andlauer Healthcare Group Inc. (AND.TO) was downgraded to B from B+ on 4/18/2022 due to a major decline in the total return index, solvency index and volatility index.
B
Buy 3/28/2022Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to B+ from B on 3/28/2022 due to a significant increase in the total return index and volatility index.
B
Buy 3/4/2022Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to B from B- on 3/4/2022 due to a significant increase in the growth index, valuation index and efficiency index. Net income increased 335.76% from $9.67M to $42.15M, earnings per share increased from $0.246 to $1.0006, and total capital increased 54.26% from $273.46M to $421.84M.
B
Buy 11/3/2021Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to B- from C+ on 11/3/2021 due to a large increase in the total return index, growth index and efficiency index. Operating cash flow increased 18.93% from $13.28M to $15.8M, net income increased 15.85% from $9.17M to $10.63M, and total revenue increased 15.29% from $75.65M to $87.22M.
C
Hold 5/12/2021Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to C+ from C on 5/12/2021 due to a significant increase in the valuation index, efficiency index and growth index. Operating cash flow increased 213.86% from $4.23M to $13.28M, total capital increased 62.37% from $175.55M to $285.03M, and EBIT increased 28.8% from $10.22M to $13.16M.
C
Hold 8/14/2020Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to C from C- on 8/14/2020 due to a noticeable increase in the solvency index, growth index and valuation index. Operating cash flow increased 155.03% from $5.82M to $14.84M, the quick ratio increased from 1.33 to 1.69, and debt to equity declined from 0.68 to 0.6.
C
Hold 7/15/2020Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to C- from E+ on 7/15/2020 due to an increase in the total return index.
E
Sell 6/2/2020Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to E+ from E on 6/2/2020 due to a large increase in the growth index, solvency index and valuation index. Earnings per share increased from $0.1428 to $0.162, debt to equity declined from 0.76 to 0.68, and EBIT increased 7.76% from $8.71M to $9.38M.
E
Sell 3/16/2020None
Andlauer Healthcare Group Inc. (AND.TO) was downgraded to E from U on 03/16/2020.
Weiss Ratings